Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 7 years of Prepaid Assets readings, the most recent being $29.7 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 16.83% to $29.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.7 million, a 16.83% increase, with the full-year FY2025 number at $42.6 million, up 112.18% from a year prior.
  • Prepaid Assets hit $29.7 million in Q1 2026 for Kiniksa Pharmaceuticals International, down from $42.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $42.6 million in Q4 2025 to a low of $10.5 million in Q1 2022.
  • Median Prepaid Assets over the past 5 years was $20.1 million (2024), compared with a mean of $22.1 million.
  • Biggest five-year swings in Prepaid Assets: decreased 11.18% in 2023 and later surged 116.67% in 2024.
  • Kiniksa Pharmaceuticals International's Prepaid Assets stood at $10.5 million in 2022, then skyrocketed by 66.44% to $17.5 million in 2023, then increased by 14.52% to $20.1 million in 2024, then soared by 112.18% to $42.6 million in 2025, then plummeted by 30.27% to $29.7 million in 2026.
  • The last three reported values for Prepaid Assets were $29.7 million (Q1 2026), $42.6 million (Q4 2025), and $30.3 million (Q3 2025) per Business Quant data.